Close
Close

Expanded Access Programs 2018

3.42857142857
3.6 from 8 votes
Date: 28 - 29 March, 2018
Location: Washington DC, USA

CBI’s Expanded Access Programs 2018 focuses on the design, development and practical implementation of early access programs. The summit convenes top industry stakeholders and regulators to examine current approaches in providing investigational, pre-launch or end-of-lifecycle drugs to patients for treatment purposes. A multi-stakeholder faculty will address key issues affecting EAPs and review the potential impact of the evolving legislative landscape.

Key Topics to Be Addressed:

  • Share best practices and review comparable processes and
    regulations between U.S. and global expanded access programs
  • Streamline policies and procedures to enable the successful
    launch and sustainability of global EAPs
  • Review industry trends in the collection of real-world data in
    expanded access programs
  • Navigate pricing, payment and reimbursement policy for
    expanded access programs
  • Discuss strategies to integrate EAPs into your drug development
    process at the busiest point of the drug development life cycle
  • Understand the clinician’s perspective on single-patient access
    and group EAPs — Consider barriers to access
3.42857142857
3.6 from 8 votes